Presentation is loading. Please wait.

Presentation is loading. Please wait.

© Copyright 2004 Frost & Sullivan. All Rights Reserved. Strategic Analysis of Brazilian Pharmaceutical Markets Recession Aftermath – Inflation and Volatile.

Similar presentations


Presentation on theme: "© Copyright 2004 Frost & Sullivan. All Rights Reserved. Strategic Analysis of Brazilian Pharmaceutical Markets Recession Aftermath – Inflation and Volatile."— Presentation transcript:

1 © Copyright 2004 Frost & Sullivan. All Rights Reserved. Strategic Analysis of Brazilian Pharmaceutical Markets Recession Aftermath – Inflation and Volatile Exchange Rates – Affects Brazilian Pharmaceutical Market Healthcare Group “The brunt of the irregular exchange rates of the Real against the dollar is borne by the end user – affecting consumer decisions in a price sensitive market. However, fiscal prudence will allow participants overcome these barriers to market growth.”

2 © Copyright 2004 Frost & Sullivan. All Rights Reserved. Industry Trends  Economy coming out of a recession which started in 2000  Sales of generic drugs to drive the overall market growth  Pharmaceutical Industry is price sensitive and sales is controlled by pharmacies and drug-stores  Dependence on import of raw materials combined with foreign exchange volatility is a major problem  Companies are going into alliances for co-marketing and production

3 © Copyright 2004 Frost & Sullivan. All Rights Reserved. Key Features Frost & Sullivan Provides:  Detailed insights into recent developments and trends  Opportunities, challenges, and strategic demand recommendations  Analyst insights on ‘hot topics’ and emerging opportunities in the pharmaceutical markets  Market sizing and in-depth end-user analysis in the markets  Market forecasts and analysis by product type, end-user application and geographic region

4 © Copyright 2004 Frost & Sullivan. All Rights Reserved. What We Offer  Coverage: Brazil  Proven methodology encompassing extensive primary and secondary data and research  Focused information and strategies that cover business and technology issues  Credible data and analysis highlighting industry dynamics  Winning strategies to help you create precise business plans

5 © Copyright 2004 Frost & Sullivan. All Rights Reserved. Who Will Benefit? Current Market Participants  Find out how you compare to the competition  Assess current and future drivers and restraints  Determine and exploit market share opportunities through new end-user application demand New Entrants  Analyze challenges associated with the industry  Calculate forecasts for end-user growth potential  Position yourself to capitalize on the market’s unmet needs Investment Community  Analyze long-term strategies of test equipment companies that offer signal sources  Determine which participants will outperform the competition  Assess attractiveness of investing in the pharmaceutical markets

6 © Copyright 2004 Frost & Sullivan. All Rights Reserved. What’s Included  Pharmaceutical market analysis and impact of variables of the economy on the market  In-depth analysis of branded pharmaceutical segment  In-depth analysis of generic drugs segment  Opportunities and strategies for new and existing companies

7 © Copyright 2004 Frost & Sullivan. All Rights Reserved.  Abbott Laboratories  Aventis  Bristol-Myers Squibb  Biosintetica  EMS Sigma Pharma  Eli Lilly  Janssen-Cilag  Merck  Medley  Novartis  Ranbaxy Laboratories Key Market Participants

8 © Copyright 2004 Frost & Sullivan. All Rights Reserved.  Call toll free: 877 GO FROST (877.463.7876)  Fax toll free: 888.690.3329  E-mail: myfrost@frost.com  Visit: www.frost.com For More Information


Download ppt "© Copyright 2004 Frost & Sullivan. All Rights Reserved. Strategic Analysis of Brazilian Pharmaceutical Markets Recession Aftermath – Inflation and Volatile."

Similar presentations


Ads by Google